MY11 Exerts Antitumor Effects through Activation of the NF-κB/PUMA Signaling Pathway in Breast Cancer

MY11 inhibited the growth of MDA-MB-231 and MCF-7 breast cancer cells by arresting the cell cycle and promoting apoptosis, through regulation of the cell cycle and apoptosis-related proteins.